Confirmed Control Closed Deal verified ConsumerConsumer HealthConsumer Health / OTC PharmaceuticalsOTC MedicinesPharmaceutical Manufacturing
Viatris OTC business acquired by Cooper Consumer Health
Cooper Consumer Health acquired Viatris OTC business, an Europe consumer health / otc pharmaceuticals brand on Oct 1, 2023. FundComb records estimated consideration of USD 2. The current comp implies EV / revenue of 3.6x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Viatris OTC business
- Acquirer
- Cooper Consumer Health
- Seller
- Viatris
- Announced
- 2023-10-01
- Geography
- Europe
- Tags
- ConsumerConsumer HealthConsumer Health / OTC PharmaceuticalsOTC MedicinesPharmaceutical Manufacturing
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
$2
Unknown | USD
Basis: FundComb estimate
EV / revenue
3.6x
unknown
Basis: FundComb estimate
EV / EBITDA
12.8x
Basis: FundComb estimate
Basis
- USD 2 unknown is a FundComb estimate. Public sources reviewed confirm the transaction, but do not independently disclose every valuation input.
- EV / revenue is shown as 3.6x based on the available comp inputs.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- EV / EBITDA is shown as 12.8x based on the available comp inputs.
Source summary
No public source summary has been published for this transaction yet.